Copyright: ©Author(s) 2026.
World J Clin Oncol. Jul 24, 2026; 17(7): 121993
Published online Jul 24, 2026. doi: 10.5306/wjco.121993
Published online Jul 24, 2026. doi: 10.5306/wjco.121993
Figure 1 Detection procedure and clinical application of circulating tumor DNA-based minimal residual disease detection in locally advanced gastric cancer.
ctDNA: Circulating tumor DNA; NGS: Next-generation sequencing; MRD: Minimal residual disease; LAGC: Locally advanced gastric cancer.
- Citation: Guo XW, Xu XX, Deng BJ, Zhou GF, Zhou Q, Gao XX, Du CZ, Qiao Z, Li HT. Harnessing minimal residual disease for precision medicine in locally advanced gastric cancer. World J Clin Oncol 2026; 17(7): 121993
- URL: https://www.wjgnet.com/2218-4333/full/v17/i7/121993.htm
- DOI: https://dx.doi.org/10.5306/wjco.121993